Author: Healthcare Propulsion Staff

Neurons receive thousands of signals via tree-like extensions called dendrites. Until now, these dendrites were thought to be relatively smooth cables that conduct electrical signals to the cell body. An international research team led by the University Hospital of Bonn (UKB), the University of Bonn, and the DZNE has now determined that this picture is incomplete. Using various advanced microscopy techniques, it has identified tiny, previously overlooked constrictions along the dendrites. These newly discovered structures, which the researchers call dendritic shaft constrictions, are only a few hundred nanometers wide – about 500 to 1,000 times thinner than a human hair…

Laser-cut cylindrical components find copious use in medical devices — in coronary and neurovascular stents, structural heart components, peripheral vascular implants, and instruments for minimally invasive procedures. The new Aerotech LaserTurn280 is a motion platform for high-volume laser machining of these cylindrical medical-device components. The LaserTurn280 is Aerotech’s new motion platform for cylindrical laser machining. Based on the PRO280LM linear table design and available with a choice of three different rotary stage drives, the system can process tube diameters from 0.3 to 30 mm. Shown here is a prototype as exhibited at Medtec Live in Stuttgart. [Image courtesy of Aerotech]Previously…

Winner of $100,000 Award Honoring Transformative Medical Technology Innovation to be Announced at San Diego Gala on October 30MOUNTAIN VIEW, Calif.–(BUSINESS WIRE)–Therapies that have transformed the treatment of cancer, postpartum hemorrhage, and calcified artery disease have been selected as finalists for the second annual Thomas J. Fogarty Innovation Prize (Fogarty Prize), made possible by the Linda and Mike Mussallem Foundation. This prestigious recognition honors an innovator or team who has developed and successfully commercialized a life-changing medical technology. The finalists will be celebrated, and the winner announced, at a black-tie gala in San Diego on October 30. The winner(s) will…

The Trump administration is promising to send $500 payments to nearly 1 million Affordable Care Act participants in 30 states, the White House’s latest effort to address cost-of-living concerns ahead of the November midterm elections.In a fact sheet on the initiative, the White House said it was issuing refunds after the Biden administration overcharged ACA enrollees though “plan exchange ‘user fees’ that were passed on to consumers in the form of higher premiums.”The White House said the checks are part of the administration’s goal to lower healthcare costs for Americans. The payments are set to go out starting in October.”President…

Americans everywhere are frustrated with high prices—for gas, groceries and especially healthcare. In poll after poll, they rank healthcare affordability among their top concerns, and it’s easy to understand why. Healthcare costs are crushing family budgets, squeezing employers and draining taxpayer dollars—consuming an ever-larger share of public resources that could go to priorities like education, infrastructure and public safety. But our debate about the solutions is too focused on who pays for care rather than why care costs so much in the first place. Take the current fight in Washington over healthcare funding. Democrats are right that coverage has to…

The Advanced Research Projects Agency for Health (ARPA-H) launched a $62.7 million effort to develop a patient-facing agentic clinical AI system for cardiovascular care, specifically to treat heart failure. The program, called Agentic AI-Enabled Cardiovascular Care Transformation (ADVOCATE), aims to create an autonomous digital member of the care team that can continuously monitor heart failure patients, provide certain aspects of care between visits and escalate issues to clinicians when needed. The selected teams will build patient-facing AI, a supervisory agentic AI and a scalable deployment plan to produce a clinical AI system for cardiovascular care. A key aspect of the…

Healthcare is growing increasingly costly and complex for patients, and there’s no shortage of finger-pointing about who’s to blame for this issue. Sachin Jain of SCAN Group Sachin Jain (SCAN Group) And it’s with that backdrop that SCAN Group CEO Sachin Jain, M.D., is releasing his new book “The Moral Alibi” on Feb. 16. Through the book, Jain aims to call on healthcare leaders to acknowledge their role in normalizing what shouldn’t be, and to take a more ethical approach to their positions. It’s a topic he’s touched on extensively in the past, across contributions to his regular Forbes column,…

The campaign group Vaccine Injured and Bereaved UK (VIBUK), which was set up to support families affected, said the scheme was not fit for purpose.”It offers too little, too late, to too few and the cost of running it shows how inefficient it is,” said the group’s representative Kate Scott, whose husband Jamie was left severely disabled by the AstraZeneca Covid vaccine.Scott called on the government to act on the recommendations from module four of the Covid public inquiry and reform the scheme.Earlier this year, the Covid inquiry’s chair, Baroness Heather Hallett, recommended increasing the payout and basing it on…

Twenty-five years after the September 11 terrorist attacks, researchers at the Icahn School of Medicine at Mount Sinai have found that environmental conditions where World Trade Center responders live may influence their long-term physical and mental health. Published in Nature Communications, the study found an association between responders exposed to higher temperatures and greater levels of air pollution and an increased risks of frailty, post-traumatic stress disorder (PTSD), and depression as they aged. In contrast, living in greener environments was associated with lower risks of all three conditions. The study, “Urban Exposures, Frailty, and Mental Illness in World Trade Center…

Early and consistently managed treatment can have a decisive impact on the course of rheumatoid arthritis and prevent permanent joint damage. An international review led by Josef S. Smolen of the Medical University of Vienna highlights which diagnostic and therapeutic measures are crucial a good outcome in patients with this disease, based on the current state of research. The analysis, published in the leading journal JAMA, summarises the evidence on the aetiology, diagnosis, treatment and prognosis of the disease. For the review, the research team from the Medical University of Vienna and Stanford University (USA) screened 15,886 scientific publications. Following…